82.07
price down icon2.04%   -1.71
after-market アフターアワーズ: 82.45 0.38 +0.46%
loading
前日終値:
$83.78
開ける:
$84.02
24時間の取引高:
241.43K
Relative Volume:
0.69
時価総額:
$1.87B
収益:
$923.71M
当期純損益:
$84.68M
株価収益率:
20.82
EPS:
3.9419
ネットキャッシュフロー:
$182.81M
1週間 パフォーマンス:
-4.60%
1か月 パフォーマンス:
+0.27%
6か月 パフォーマンス:
+7.59%
1年 パフォーマンス:
+24.16%
1日の値動き範囲:
Value
$81.97
$85.90
1週間の範囲:
Value
$81.97
$87.19
52週間の値動き範囲:
Value
$62.60
$99.50

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
名前
Ani Pharmaceuticals Inc
Name
セクター
Healthcare (1096)
Name
電話
(609) 759-1810
Name
住所
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, MN
Name
職員
970
Name
Twitter
Name
次回の収益日
2026-08-14
Name
最新のSEC提出書
Name
ANIP's Discussions on Twitter

Compare ANIP vs TAK, HLN, TEVA, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANIP icon
ANIP
Ani Pharmaceuticals Inc
82.07 1.87B 923.71M 84.68M 182.81M 3.9419
TAK icon
TAK
Takeda Pharmaceutical Co Adr
16.56 52.88B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.76 42.98B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.95 38.37B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
75.56 31.68B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
547.06 23.22B 3.17B 1.29B 1.01B 27.09

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 開始されました H.C. Wainwright Buy
2025-03-14 開始されました Jefferies Buy
2025-03-12 開始されました JP Morgan Overweight
2024-12-11 開始されました Leerink Partners Outperform
2024-10-11 開始されました Piper Sandler Overweight
2024-03-15 開始されました CapitalOne Overweight
2023-08-22 繰り返されました H.C. Wainwright Buy
2023-03-01 開始されました Guggenheim Buy
2022-09-07 開始されました H.C. Wainwright Buy
2021-11-02 開始されました Truist Buy
2020-05-07 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-09-12 開始されました Guggenheim Buy
2019-05-10 ダウングレード Raymond James Strong Buy → Outperform
2017-10-16 繰り返されました Canaccord Genuity Buy
2017-07-31 開始されました Canaccord Genuity Buy
2017-02-22 ダウングレード ROTH Capital Buy → Neutral
2016-06-23 開始されました Raymond James Strong Buy
2016-05-24 ダウングレード Standpoint Research Buy → Hold
2015-11-13 開始されました Standpoint Research Buy
2015-09-28 アップグレード ROTH Capital Neutral → Buy
2015-08-05 繰り返されました Oppenheimer Outperform
2015-08-04 繰り返されました ROTH Capital Neutral
2015-07-31 繰り返されました Oppenheimer Outperform
2015-07-15 繰り返されました ROTH Capital Neutral
2015-06-23 繰り返されました Oppenheimer Outperform
2015-05-18 繰り返されました ROTH Capital Neutral
2015-05-06 繰り返されました Oppenheimer Outperform
2015-04-10 ダウングレード ROTH Capital Buy → Neutral
2015-02-26 繰り返されました ROTH Capital Buy
2015-02-18 繰り返されました Oppenheimer Outperform
すべてを表示

Ani Pharmaceuticals Inc (ANIP) 最新ニュース

pulisher
Jul 11, 2026

ANI Pharmaceuticals (ANIP) Recalls HydrOXYzine Solution, Is The Pullback A Valuation Opportunity? - Sahm

Jul 11, 2026
pulisher
Jul 09, 2026

ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge - Yahoo Finance

Jul 09, 2026
pulisher
Jul 09, 2026

Enterprise value to revenue forward of ANI Pharmaceuticals, Inc. – NASDAQ:ANIP - TradingView

Jul 09, 2026
pulisher
Jul 07, 2026

Price to sales forward of ANI Pharmaceuticals, Inc. – NASDAQ:ANIP - TradingView

Jul 07, 2026
pulisher
Jul 07, 2026

Form 144 ANI Pharmaceuticals For: 7 July By Investing.com - Investing.com India

Jul 07, 2026
pulisher
Jul 07, 2026

ANIP (ANIP) insider sales reported: Walsh sold 13,973 shares in May 2026 - Stock Titan

Jul 07, 2026
pulisher
Jul 07, 2026

Is Stronger Free Cash Flow Signalling a Shift in ANI Pharmaceuticals' Capital Efficiency Story (ANIP)? - Sahm

Jul 07, 2026
pulisher
Jul 07, 2026

Ani Pharmaceuticals SVP & CFO Stephen Carey sells $284k in stock - Investing.com Australia

Jul 07, 2026
pulisher
Jul 06, 2026

Form 4 ANI Pharmaceuticals Inc For: 6 July By Investing.com - Investing.com Nigeria

Jul 06, 2026
pulisher
Jul 06, 2026

ANI Pharmaceuticals (ANIP) CFO sells 3,313 shares after option exercise - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

Price to earnings forward of ANI Pharmaceuticals, Inc. – NASDAQ:ANIP - TradingView

Jul 06, 2026
pulisher
Jul 05, 2026

ANI Pharmaceuticals set to report earnings amid estimate cuts - Investing.com

Jul 05, 2026
pulisher
Jun 30, 2026

Insider Sell: Stephen Carey Sells Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus

Jun 30, 2026
pulisher
Jun 30, 2026

ANI Pharmaceuticals (ANIP) CFO Stephen Carey sells 2,850 shares under Rule 10b5-1 plan - Stock Titan

Jun 30, 2026
pulisher
Jun 26, 2026

ANI Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ANIP) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

ANI Pharmaceuticals: Rare Disease Growth At A Generics Multiple (NASDAQ:ANIP) - Seeking Alpha

Jun 26, 2026
pulisher
Jun 26, 2026

ANIP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

ANI Pharmaceuticals, Inc. Actuals & Estimates (BOATS:ANIP) - TradingView

Jun 25, 2026
pulisher
Jun 21, 2026

ANI Pharmaceuticals (ANIP) Stock Could Be 29.5% Below Fair Value After Recent Pullback - Sahm

Jun 21, 2026
pulisher
Jun 20, 2026

ANI Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $114.17, Implies 44% Upside - TradingView

Jun 20, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

ANI Pharmaceuticals Inc (ANIP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

Insider Sell: Meredith Cook Sells 500 Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus

Jun 16, 2026
pulisher
Jun 15, 2026

Ani Pharmaceuticals Sr. VP Cook sells $41,015 in stock - Investing.com UK

Jun 15, 2026
pulisher
Jun 15, 2026

Ani Pharmaceuticals Sr. VP Cook sells $41,015 in stock By Investing.com - Investing.com Nigeria

Jun 15, 2026
pulisher
Jun 15, 2026

ANI Pharmaceuticals (ANIP) VP sells 500 shares under 10b5-1 plan - Stock Titan

Jun 15, 2026
pulisher
Jun 12, 2026

ANI Pharmaceuticals (ANIP) Stock Valuation After Recent Momentum And Cortrophin Growth Prospects - Sahm

Jun 12, 2026
pulisher
Jun 11, 2026

Insider Sell: Thomas Haughey Sells 2,000 Shares of ANI Pharmaceu - GuruFocus

Jun 11, 2026
pulisher
Jun 10, 2026

Ani Pharmaceuticals director Thomas Haughey sells $161,760 in stock - Investing.com

Jun 10, 2026
pulisher
Jun 10, 2026

Ani Pharmaceuticals director Thomas Haughey sells $161,760 in stock By Investing.com - Investing.com India

Jun 10, 2026
pulisher
Jun 10, 2026

ANI Pharmaceuticals (ANIP) director awarded 4,357 restricted shares vesting in 2027 - Stock Titan

Jun 10, 2026
pulisher
Jun 10, 2026

ANI Pharmaceuticals (ANIP) director receives 4,357-share restricted stock award - Stock Titan

Jun 10, 2026
pulisher
Jun 10, 2026

ANI Pharmaceuticals (ANIP) director sells 2,000 shares under plan - Stock Titan

Jun 10, 2026
pulisher
Jun 10, 2026

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings? - Yahoo Finance

Jun 10, 2026
pulisher
Jun 10, 2026

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push - Yahoo Finance

Jun 10, 2026
pulisher
Jun 10, 2026

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth - Yahoo Finance

Jun 10, 2026
pulisher
Jun 10, 2026

CenterBook Partners LP Purchases Shares of 19,226 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Jun 10, 2026
pulisher
Jun 09, 2026

Ani Pharmaceuticals SVP & CFO Stephen Carey sells $264,960 in stock - Investing.com UK

Jun 09, 2026
pulisher
Jun 09, 2026

Ani Pharmaceuticals SVP & CFO Stephen Carey sells $264,960 in stock By Investing.com - Investing.com South Africa

Jun 09, 2026
pulisher
Jun 09, 2026

[Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity - Stock Titan

Jun 09, 2026

Ani Pharmaceuticals Inc (ANIP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$51.94
price down icon 3.42%
RDY RDY
$13.19
price down icon 5.04%
$24.82
price up icon 0.81%
$177.11
price down icon 1.91%
$16.27
price down icon 0.43%
$547.06
price down icon 0.98%
大文字化:     |  ボリューム (24 時間):